Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Endoplasmic reticulum (ER) stress is induced by various conditions, such as inflammation and the presence of excess nutrients. Abnormal accumulation of unfolded proteins leads to the activation of a collective signaling cascade, termed the unfolded protein response (UPR). ER stress is reported to perturb hepatic insulin response metabolism while promoting insulin resistance. Here, we report that ER stress regulates the de novo biosynthesis of sphingolipids via the activation of serine palmitoyltransferase (SPT), a rate-limiting enzyme involved in the de novo biosynthesis of ceramides. We found that the expression levels of Sptlc1 and Sptlc2, the major SPT subunits, were upregulated and that the cellular concentrations of ceramide and dihydroceramide were elevated by acute ER stress inducers in primary hepatocytes and HepG2 cells. Sptlc2 was upregulated and ceramide levels were elevated by tunicamycin in the livers of C57BL/6J wild-type mice. Analysis of the Sptlc2 promoter demonstrated that the transcriptional activation of Sptlc2 was mediated by the spliced form of X-box binding protein 1 (sXBP1). Liver-specific Sptlc2 transgenic mice exhibited increased ceramide levels in the liver and elevated fasting glucose levels. The insulin response was reduced by the inhibition of the phosphorylation of insulin receptor β (IRβ). Collectively, these results demonstrate that ER stress induces activation of the de novo biosynthesis of ceramide and contributes to the progression of hepatic insulin resistance via the reduced phosphorylation of IRβ in hepatocytes.
Abstract
Endoplasmic reticulum (ER) stress is induced by various conditions, such as inflammation and the presence of excess nutrients. Abnormal accumulation of unfolded proteins leads to the activation of a collective signaling cascade, termed the unfolded protein response (UPR). ER stress is reported to perturb hepatic insulin response metabolism while promoting insulin resistance. Here, we report that ER stress regulates the de novo biosynthesis of sphingolipids via the activation of serine palmitoyltransferase (SPT), a rate-limiting enzyme involved in the de novo biosynthesis of ceramides. We found that the expression levels of Sptlc1 and Sptlc2, the major SPT subunits, were upregulated and that the cellular concentrations of ceramide and dihydroceramide were elevated by acute ER stress inducers in primary hepatocytes and HepG2 cells. Sptlc2 was upregulated and ceramide levels were elevated by tunicamycin in the livers of C57BL/6J wild-type mice. Analysis of the Sptlc2 promoter demonstrated that the transcriptional activation of Sptlc2 was mediated by the spliced form of X-box binding protein 1 (sXBP1). Liver-specific Sptlc2 transgenic mice exhibited increased ceramide levels in the liver and elevated fasting glucose levels. The insulin response was reduced by the inhibition of the phosphorylation of insulin receptor β (IRβ). Collectively, these results demonstrate that ER stress induces activation of the de novo biosynthesis of ceramide and contributes to the progression of hepatic insulin resistance via the reduced phosphorylation of IRβ in hepatocytes.
참고문헌 (53)
- Barr, E. L., "HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study", Diabetologia, 53, pp.79~88 (2010)
- Hastie, C. E., "Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention", Eur. Heart J, 31, pp.222~226 (2010)
- Roberts, A. W., "Review article : Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease-do we need to screen our patients?", Diab. Vasc. Dis. Res, 6, pp.153~163 (2009)
- Bradbury, M. W., "Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis", Am. J. Physiol. Gastrointest. Liver. Physiol, 290, pp.G194~G198 (2006)
- Unger, R. H., "Lipid overload and overflow: metabolic trauma and the metabolic syndrome", Trends Endocrinol. Metab, 14, pp.398~403 (2003)
- Listenberger, L. L., "Triglyceride accumulation protects against fatty acidinduced lipotoxicity", Proc. Natl Acad. Sci. USA, 100, pp.3077~3082 (2003)
- Jaeschke, A., "Metabolic stress signaling mediated by mixed-lineage kinases", Mol. Cell, 27, pp.498~508 (2007)
- Jeong, T., "Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase", J. Clin. Invest, 101, pp.905~912 (1998)
- Hanada, K., "Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism", Biochim. Biophys. Acta, 1632, pp.16~30 (2003)
- Weiss, B., "Human and murine serine-palmitoyl-CoA transferase-cloning, expression and characterization of the key enzyme in sphingolipid synthesis", Eur. J. Biochem, 249, pp.239~247 (1997)
- Hojjati, M. R., "Serine palmitoyl-CoA transferase(SPT)deficiency and sphingolipid levels in mice", Biochim. Biophys. Acta, 1737, pp.44~51 (2005)
- Li, Z., "Liver-specific deficiency of serine palmitoyltransferase subunit 2decreases plasma sphingomyelin and increases apolipoprotein E levels", J. Biol. Chem, 284, pp.27010~27019 (2009)
- Hornemann, T., "Cloning and initial characterization of a new subunit for mammalian serinepalmitoyltransferase", J. Biol. Chem, 281, pp.37275~37281 (2006)
- Hornemann, T., "Is the mammalian serine palmitoyltransferase a high-molecular-mass complex?", Biochem. J, 405, pp.157~164 (2007)
- Stratford, S., "Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt", protein kinase B, 2004, pp.279, 36608~36615
- Holland, W. L., "Sphingolipids, insulin resistance, and metabolic disease : new insights from in vivo manipulation of sphingolipid metabolism", Endocr. Rev, 29, pp.381~402 (2008)
- Park, T. S., "Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice", Circulation, 110, pp.3465~3471 (2004)
- Holland, W. L., "Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance", Cell Metab, 5, pp.167~179 (2007)
- Park, T. S., "Ceramide is a cardiotoxin in lipotoxic cardiomyopathy", J. Lipid Res, 49, pp.2101~2112 (2008)
- Rutkowski, D. T., "UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators", Dev. Cell, 15, pp.829~840 (2008)
- Kaufman, R. J., "Orchestrating the unfolded protein response in health and disease", J. Clin. Invest, 110, pp.1389~1398 (2002)
- Hampton, R. Y., "ER stress response : getting the UPR hand on misfolded proteins", Curr. Biol, 10, pp.R518~R521 (2000)
- Schroder, M., "The mammalian unfolded protein response", Annu. Rev. Biochem, 74, pp.739~789 (2005)
- Malhi, H., "Endoplasmic reticulum stress in liver disease", J. Hepatol, 54, pp.795~809 (2011)
- Hotamisligil, G. S., "Endoplasmic reticulum stress and the inflammatory basis of metabolic disease", Cell, 140, pp.900~917 (2010)
- Ozcan, U., "Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes", Science, 306, pp.457~461 (2004)
- Renton, K. W., "Effects of polyribonoinosinic acid polyribocytidylic acid and a mouse interferon preparation on cytochrome P-450-dependent monooxygenase systems in cultures of primary mouse hepatocytes", Mol. Pharmacol, 14, pp.672~681 (1978)
- Chang, Z. Q., "Endotoxin activates de novo sphingolipid biosynthesis via nuclear factor kappa B-mediated upregulation of Sptlc2", Prostaglandins Other Lipid Mediat, 94, pp.44~52 (2011)
- Rutti, M. F., "An improved method to determine serine palmitoyltransferase activity", J. Lipid Res, 50, pp.1237~1244 (2009)
- Yoo, H. H., "Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts", J. Chromatogr. B. Anal. Technol. Biomed. Life Sci, 843, pp.327~333 (2006)
- Lee, S. Y., "Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice", Hepatology, 62, pp.135~146 (2015)
- Ryu, D., "Endoplasmic reticulum stress promotes LIPIN2-dependent hepatic insulin resistance", Diabetes, 60, pp.1072~1081 (2011)
- Lee, A. H., "Regulation of hepatic lipogenesis by the transcription factor XBP1", Science, 320, pp.1492~1496 (2008)
- Chan, S. M., "Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress", Diabetes, 62, pp.2095~2105 (2013)
- Ryu, D., "TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1", Cell Metab, 9, pp.240~251 (2009)
- Shen, J., "ER stress regulation of ATF6localization by dissociation of BiP", GRP78 binding and unmasking of Golgi localization signals, 2002, pp.3, 99~111
- Bertolotti, A., "qDynamic interaction of BiP and ER stress transducers in the unfolded-protein response", Nat. Cell Biol, 2, pp.326~332 (2000)
- Harding, H. P., "An integrated stress response regulates amino acid metabolism and resistance to oxidative stress", Mol. Cell, 11, pp.619~633 (2003)
- Sidrauski, C., "The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response", Cell, 90, pp.1031~1039 (1997)
- Yoshida, H., "XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor", Cell, 107, pp.881~891 (2001)
- Yoshida, H., "Identification of the cisacting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors", J. Biol. Chem, 273, pp.33741~33749 (1998)
- Kokame, K., "Identification of ERSE-II, a new cis-acting element responsible for the ATF6-dependent mammalian unfolded protein response", J. Biol. Chem, 276, pp.9199~9205 (2001)
- Pettus, B. J., "Ceramide in apoptosis : an overview and current perspectives", Biochim. Biophys. Acta, 1585, pp.114~125 (2002)
- Oskouian, B., "Cancer treatment strategies targeting sphingolipid metabolism", Adv. Exp. Med. Biol, 688, pp.185~205 (2010)
- Bartke, N., "Bioactive sphingolipids: metabolism and function", J. Lipid Res, 50(Suppl.), pp.S91~S96 (2009)[DOI]
- Holland, W. L., "Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice", J. Clin. Invest, 121, pp.1858~1870 (2011)
- Ussher, J. R., "Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption", Diabetes, 59, pp.2453~2464 (2010)
- Li, Z., "Reducing plasma membrane sphingomyelin increases insulin sensitivity", Mol. Cell Biol, 31, pp.4205~4218 (2011)
- Hirosumi, J., "A central role for JNK in obesity and insulin resistance", Nature, 420, pp.333~336 (2002)
- 김군태, "Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion", 지질·동맥경화학회지, 9(2), pp.291~303 (2020), 한국지질동맥경화학회[DOI]
- Chaurasia, B., "Targeting a ceramide double bond improves insulin resistance and hepatic steatosis", Science, 365, pp.386~392 (2019)
- Chocian, G., "High fat diet induces ceramide and sphingomyelin formation in rat’s liver nuclei", Mol. Cell Biochem, 340, pp.125~131 (2010)
- Nagy, C., "Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test(OGTT)and Insulin Tolerance Test(ITT)", J. Vis. Exp, 131, pp.53372~ (2018)